Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies.
Serrenho I, Rosado M, Dinis A, M Cardoso C, Grãos M, Manadas B, Baltazar G.
Int J Mol Sci. 2021 Mar 19;22(6):3142. doi: 10.3390/ijms22063142.
PMID:33808671
The Role of PKM2 in Multiple Signaling Pathways Related to Neurological Diseases.
Zhang X, Lei Y, Zhou H, Liu H, Xu P.
Mol Neurobiol. 2024 Aug;61(8):5002-5026. doi: 10.1007/s12035-023-03901-y. Epub 2023 Dec 29.
PMID:38157121
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial.
Mercuri E, Muntoni F, Baranello G, Masson R, Boespflug-Tanguy O, Bruno C, Corti S, Daron A, Deconinck N, Servais L, Straub V, Ouyang H, Chand D, Tauscher-Wisniewski S, Mendonca N, Lavrov A; STR1VE-EU study group.